Archives
- 2026-11
- 2026-10
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
PNU 74654: Wnt Signaling Pathway Inhibitor
2026-08-25
PNU 74654 is a small-molecule Wnt signaling pathway inhibitor for mechanistic studies of Wnt/β-catenin signaling inhibition. Its defined identity, DMSO solubility, cold-storage guidance, and research-only status support controlled cancer research and stem cell research workflows.
Poly-PR, NEAT1, and HSP70 Control of TDP-43
2026-08-25
Agnihotri et al. show that C9ORF72-associated poly-PR promotes NEAT1-dependent TDP-43 nuclear condensates whose material properties change over time as HSP70 first colocalizes with, and later leaves, these structures. The study provides a mechanistic framework linking stress duration, condensate fluidity, TDP-43 oligomerization, and neurotoxicity in ALS/FTD-related cellular models.
ISRIB (trans-isomer) in Memory and ISR Research
2026-08-24
ISRIB (trans-isomer) connects molecular ISR control with practical ER stress, apoptosis, and inflammation-associated memory workflows. Its downstream eIF2B activity enables researchers to distinguish accelerated forgetting from impaired retrieval while supporting translational studies in neurodegenerative disease models.
Spatially Patterned Kidney Assembloids for Disease Modeling
2026-08-24
Huang et al. developed mouse and human kidney progenitor assembloids that reproduce key aspects of nephron–collecting duct self-assembly, spatial organization, maturation, and function. Their in vivo-grown PKD2-deficient human model also recapitulated polycystic kidney disease features and revealed interactions among cyst epithelium, stroma, and macrophages.
BIBR 1532: Telomerase Inhibitor Workflow
2026-08-23
BIBR 1532 provides a practical way to test hTERT-dependent telomerase activity, distinguish acute apoptosis from gradual telomere attrition, and design combination studies in cancer models. This workflow pairs concentration-response testing with orthogonal telomerase, transcriptional, cell-cycle, and apoptosis readouts.
Ivermectin Beyond the Parasite: Translational Strategy
2026-08-22
Ivermectin is more than a familiar broad-spectrum anti-parasitic: it is a mechanistically defined research tool that can support rigorous parasitology drug development while informing carefully bounded cross-disciplinary hypotheses. This thought-leadership article connects parasite neuromuscular pharmacology with the GSDMC-driven stemness and immune-evasion biology reported in pancreatic ductal adenocarcinoma, without overstating evidence for oncology repurposing.
TBK1, Microglial Pyroptosis, and Diabetic Neuropathy
2026-08-21
Liao et al. identify TANK-binding kinase 1 (TBK1) as a mechanistic driver of painful diabetic neuropathy through microglial pyroptosis and NLRP3 inflammasome activation. Their combination of spinal knockdown, pharmacological inhibition, behavioral testing, and tissue-level analyses supports TBK1 as a potential target for inflammation-linked diabetic pain.
HMGCS2, Lyso-PC, and Pulmonary Fibrosis
2026-08-20
Yang et al. identify injured alveolar epithelial type II cells as a major source of accumulated lysophosphatidylcholine in experimental pulmonary fibrosis and connect this lipid imbalance to fibroblast activation. Their data place HMGCS2, PPARα, CPT1A, and CPT2 within an epithelial lipid-degradation pathway that may help explain how epithelial injury becomes persistent fibrotic signaling.
SW033291: 15-PGDH Inhibition Beyond Muscle
2026-08-20
SW033291 is a potent 15-PGDH inhibitor for studying prostaglandin E2 elevation, hematopoietic stem cell expansion, and tissue regeneration. This guide translates enzyme and cellular potency into assay decisions while placing new muscle-repair findings in their proper experimental context.
Stereotactic NSCLC Models of Brain and Spinal Metastases
2026-08-19
The 2024 Heliyon study established brain and spinal cord metastasis models of non-small cell lung cancer by combining PC-9 Luc cells with controlled intracranial stereotactic injection. Its comparison of inoculation position, cell number, IVIS optical monitoring, and histological confirmation provides a practical framework for reproducible CNS tumor modeling while highlighting important limits on biological interpretation.
Bestatin Stimulates Endothelial Invasion in Fibrin
2026-08-19
The reference study showed that Bestatin, also known as Ubenimex, can promote rather than suppress microvascular endothelial invasion and capillary-like tube formation when cells are embedded in a fibrin matrix. This context-dependent result challenges a simple CD13-centered explanation of Bestatin activity and highlights the need to interpret aminopeptidase inhibition within the proteolytic environment of angiogenic tissues.
AM 281: CB1 Cannabinoid Receptor Antagonist
2026-08-18
AM 281 provides a selective pharmacological lever for testing how CB1 signaling, astrocytic GLT-1, and glutamate excitotoxicity shape cognitive outcomes after brain injury. This workflow-oriented guide connects receptor pharmacology with tissue kinetics, behavioral testing, and troubleshooting for memory impairment research and addiction-related models.
Morin: Podocyte Energy & Assay Workflows
2026-08-18
Morin combines flavonoid bioactivity with a mechanistically useful route for studying podocyte mitochondrial stress and adenosine 5′-monophosphate deaminase signaling. This workflow-focused guide also covers formulation, fluorescence-based aluminum assays, controls, and troubleshooting for more reproducible disease-model experiments.
SB-3CT and the MMP9–PNN Plasticity Axis
2026-08-17
A translational perspective on how SB-3CT can be used to interrogate MMP-2 and MMP-9 in extracellular matrix remodeling, cancer metastasis studies, and neural plasticity research inspired by new Adamtsl3–MMP9 findings.
Light-Controlled RNA Release for Gene Therapy
2026-08-17
The 2026 Trends in Biotechnology study introduces a rationally designed light-inducible RNA-releasing protein (LIRP) that controls therapeutic protein production at the translation stage. By combining reversible light responsiveness with AAV and cell-based delivery strategies, the work demonstrates on-demand regulation in obesity and retinal disease models while highlighting key requirements for clinical translation.
8718 records 10/582 page Previous Next First page 上5页 678910 下5页 Last page